The Latest Cardiac and Vascular News
SANTA ROSA, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held global medical device company focused on advancing innovative therapies for the interventional treatment of vascular disease, today announced the appointment of Steve Deitsch to its Board of Directors. Mr. Deitsch brings more than 25 years of global leadership experience across medtech and the broader healthcare sector. He currently serves as Chief Executive Officer of Caristo Diagnostics, a global leader in AI technology for
MINNEAPOLIS, April 20, 2026 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today the nomination of Michael Dale to serve on its Board of Directors. Mr. Dale will stand for election at the annual meeting of stockholders scheduled for June 1, 2026.
WILMINGTON, Del., March 6, 2026 /PRNewswire/ — Valcare Medical, Inc., a pioneer in transcatheter mitral valve repair solutions, today announced the appointment of two new members to its Board of Directors: Jeffrey B. Jump and Jacques Séguin, MD, PhD. These renowned experts in the…
COPENHAGEN, Denmark, Dec. 10, 2025 /PRNewswire/ — CathVision, a medical technology company dedicated to improving clinical outcomes in cardiac electrophysiology through high-fidelity signal acquisition and intelligent software, today announced two major milestones: the appointment of…
